LHKOREA12

<IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364803864697.gif" width=541 height=604>   ※ 출처 : Big Multinational Pharma in China, Datamonitor(2013.1) ※ 생명공학정책연구센터 재가공 <그림 70-1> 글로벌 제약기업의 중국 진출 시기     □ 중국내 13개 글로벌 기업별 사업 요약    ❍ ABBOTT    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 4,000여 명    - 제품 포트폴리오      ▪ ABBOTT는 중국내 다양한 질병대상 17개 의약품으로 구성된 포트폴리오를 구축       ▪ Humira(자가면역치료제)는 ABBOTT의 주력 제품으로 2010년 2월 승인되어, 류머티스성관절염 치료제로 승인       ▪ 중국내 대기업인 Sinopharma와 협력으로 중국 전역에 Humira를 공급     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364805781259.gif" width=585 height=121>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-2> ABBOT 중국 사업 연혁     <표 70-1> ABBOT 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>2012.02</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=119> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>Bisino BioTech.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>판매 협약</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>화학시약 공급 및 운영 컨설팅</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>2009.04</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=119> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>HUYA Bio.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>R&D 협약</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>네트워크 활용 R&D 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=76 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>2006.12</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=76 vAlign=center width=119> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>Shanghi Meiyou Pharma.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=76 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>조인트벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=76 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=76 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0 align=center>중국내 의약품 생산</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ AstraZeneca    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 5,000여 명    - 제품 포트폴리오      ▪ 다양한 질병 대상의 22개 제품으로 구성된 포트폴리오를 구성하고 있음      ▪ Iressa(항암제)는 국가상환 의약품리스트(NRDL)에 오르지 않았음에도 2010년 15.7백만 달러 판매 기록      ▪ Seretide(호흡기 질환, AstraZeneca)는 Symbicort(GSK)와 경쟁구도를 형성하고 있으나, 2010년 Seretide가 NRDL에        포함되며 판매가 급증할 것으로 전망     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364805901322.gif" width=583 height=120>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-3> AstraZeneca 중국 사업 연혁     <표 70-2> AstraZeneca 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2012.10</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Ironwood Pharma.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>개발 및 상용화 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>$25m</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Iinaclotide(과민성 대장 증상 치료제 임상 3상 진행</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2012.09</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Wuxi App Tec</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>MEDI5117(자가면역 및 염증 치료제) 임상 1상 진행 예정</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.12</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Hutchison MediPharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>개발 및 상용화 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>$140m</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>HMPL-504(표적항암치료제) 개발 및 판매 협약 체결</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Amoy Diagnostics</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>연구 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=54 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>ADx-ARMS를 이용한 EGFR 유전자 변형 감지 기술 연구</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2007.09</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Peking Univ.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>-</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>약리 및 안정성 평가를 위한 임상약리협회 구성</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ BAYER AG    - Headquater 소재 : 베이징    - 중국내 고용 인력 : 6,000여 명    - 제품 포트폴리오      ▪ 20여 개의 제품 포트폴리오 중 Glcobay가 중국내 첫 SFDA 승인을 획득하며 성공적인 판매를 기록       ▪ 이외 Adalat(고혈압 치료제), Nexavar(항암제) 등이 중국내 높은 판매실적을 보이고 있는 것으로 분석      ※ (Adalat) 2010 매출 ?140m, 2006~2010 연평균 37% 성장률 기록, (Nexavar) 2010 매출 ?45m, 2007~2010 연평균 57%          성장률 기록     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364805956650.gif" width=569 height=155>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-4> BAYER AG 중국 사업 연혁     <표 70-3> BAYER AG 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>National Phrma. Engineering Research Center</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>약물전달 시스템 연구</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>생분해성 약물 주입 전달 시스템 연구 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.07</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>General Hospital of the People's Liberation Army</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>연구 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=60 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>General Hospital에 대한 연구재정지원 및 연구자양성, 공동연구 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2009.07</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>SciGen</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱 및 분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>$43m</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>재조합 인슐린 판매 및 중국내 공급 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2009.03</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Tsinghua Univ.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공동 연구</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>신약개발 3D 단백질 구조 규명 공동 연구</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2006.07</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Biocon</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱 및 마케팅</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Insugen(재조합 인슐린) 라이센싱 및 마케팅 협약</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ BOEHRINGER INGELHEIM GMBH    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 2,700여 명    - 제품 포트폴리오      ▪ 호흡기 및 심혈관 치료제 중심의 포트폴리오를 구축하고 있으며, Mucosolvan, Atrovent, Combivent(호흡기질환 치료제),        등이 NRDL 리스트에 포함       ▪ Spiriva의 제너릭 유형인 Su Le(Chai Tai Tianqing)가 유사한 시기에 중국내 출시되며, 판매 소송을 벌였으나 Spiriva의        패소로 종결     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806026572.gif" width=577 height=139>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-5> BOEHRINGER INGELHEIM GMBH 중국 사업 연혁        - 주요 전략       ▪ 중국 전역의 의약품 공급 및 중국 환자 대상의 임상시험을 집중하는 전략을 추구     <표 70-4> BOEHRINGER INGELHIEM GMBH 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=97 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2008.08</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=97 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Zhejiang Hisoar Pharmaceutical</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=97 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>생산 협약</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=97 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=97 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Boehringer Ingeleim의 의약품 생산 협력 및 기술적 노하우 제공</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ BRISTOL-MYERS SQUIBB CO.    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 2,500여 명    - 제품 포트폴리오       ▪ 항당뇨, 항감염 중심의 12개 제품을 중심으로 포트폴리오를 구축하고 있으며, 그 중 10개 제품이 NRDL 리스트에 등록      ▪ Baraclude(B형 간염 치료제)가 2005년 중국 SFDA에 승인을 획득하며, 2011년 BRISTOL-MYERS SQUIBB의 중국내 매출        40%를 기록      ▪ 주요 제품 중 Baraclude만이 중국내 특허권을 보유하며 제너릭의 공세에 대응      ▪ 2~3년내 항응고제, 당뇨병 치료제 등 새로운 제품의 출시를 계획     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806123259.gif" width=596 height=149>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-6> BRISTOL-MYERS SQIBB CO. 중국 사업 연혁     <표 70-5> BRISTOL-MYERS SQIBB CO. 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2012.05</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Tsinghua Univ.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>연구개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Tsinghua Univ. 재정 지원, 종양 및 면역 질환novel target 확보 및 승인 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=47 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.03</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=47 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Wuxi App Tec</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=47 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>생산 협약</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=47 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=47 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Wuxi App Tec의 cGMP 수준 분석 설비를 이용한안정성 시험 및 기타 서비스 제공</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Simcere</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공동개발 및 상용화</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=62 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>BMS-795311(고지혈증 치료제) 공동연구 및 중국내 Simcere 특허 기반 확보</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ ELI LILLY & CO.    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 4,000여 명    - 제품 포트폴리오       ▪ 다양한 질병군 14개 제품 중 9개 제품이 NRDL에 포함되어 있는 제품 포트폴리오를 구축       ▪ Byetta(당뇨병 치료제)가 중국 SFDA의 승인을 획득하였으나, 현재 NRDL 리스트에 포함되지 않음       ▪ Byetta 개발로 중국내 상당수의 beta-cell 기능장에 환자가 도움을 받을 것으로 보이나 바이오시밀러의 공세를 받을 전망     <IMG style="WIDTH: 570px; HEIGHT: 128px" title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806181775.gif" width=577 height=123>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-7> ELI LILLY & CO. 중국 사업 연혁     <표 70-6> ELI LILLY & CO. 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=119 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2007.09</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=119 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Hutchison MediPharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=119 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>의약 개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=119 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=119 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>종양 및 염증 중심의 의약품 연구개발 협력 ,Hutchison MediPharma 임상 후보물질 개발 및 Eli Lilly의 Drug Filing, 임상시험 협력</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ GLAXOSMITHKLINE PLC    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 5,000여 명    - 제품 포트폴리오      ▪ 다양한 질병군의 28개 제품의 포트폴리오를 구축하고 있으며, 이 중 24개의 제품이 NRDL에 등록       ▪ Seretide(천식 치료제) 등 호흡기 질환 치료제가 급속하게 중국내 시장을 점유하고 있으며, 중국내 R&D 한계로 인하여        당분간 제너릭의 피해가 없을 전망     <IMG style="WIDTH: 576px; HEIGHT: 147px" title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806242666.gif" width=594 height=150>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-8> GLAXOSMITHKLINE 중국 사업 연혁     <표 70-7> GLAXOSMITHKLINE 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2012.03</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Hanmi Pharma.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공동연구 및 공동판매</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Hanmi의 제형연구, 비임상 및 생산 기술 협력, GSK의 후반부 임상 수행 및 규제 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>ProteoTech</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파킨슨병 및 퇴행성신경질환 관련 연구 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Signum Biosciences</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Signum의 특허 및 신경질환 스크리닝 기술 협력, GSK의 연구개발 지원</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.08</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Sinopharm 외 2</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공급 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>지역별 GSK. 백신 공급 담당 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2009.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Gilead</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>상용화</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Viread(HIV 치료제) 라이센싱 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2009.10</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Jiang Walvax Biotech</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트 벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>홍역, 볼거리, 풍진 등 성인백신 개발 및 생산 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2009.06</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Shenzhen Neptunus Interlong</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트 벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>계절성, 판데믹 인플루엔자 백신 개발 및 생산 협약</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ JOHNSON & JOHNSON    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 7,000여 명    - 제품 포트폴리오      ▪ Remicade(종양 및 염증 치료제)가 크론병, 류마티스 관절염, 강직성 척추염에 대하여 중국내 SFDA의 승인을 획득       ▪ 판상형 건선 치료제가 현재 임상 3상을 진행하고 있으며, 궤양성 대장염 관련 치료제가 임상 3상에 진입할 전망       ▪ Stelara(판상형 건선 치료제)가 2012년 임상 3상을 마쳤으며, 2013년 말 승인을 획득할 것으로 기대       ▪ Stelara가 시장에 진입한다면 Pfizer의 Enbrel, Abbott의 Humira와 경쟁할 것으로 전망     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806297884.gif" width=573 height=152>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-9> JOHNSON&JOHNSON 중국 사업 연혁     <표 70-8> JOHNSON&JOHNSON 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.03</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>WuXi Pharma Tech</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>연구개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>독성 검사 및 효력 검증 기술 제공</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2008.10</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>WuXi Pharma Tech</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>-</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Johnson&Johnson의 의약품 발굴 서비스 공급,Wuxi Pharma Tech의 의약 발굴 및 분석개발 서비스, 제형, 비임상 협력</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ MERCK & CO.    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 5,000여 명    - 제품 포트폴리오       ▪ 2012년 Singulair(천식 치료제)의 미국내 특허가 만료됨에 따라 제너릭의 공세로 매출 감소가 전망       ▪ 중국내에서도 Otsuka, Shandong Lunan Pharma의 제너릭이 생산될 것으로 판단되며, 중국내 Singulair의 판매에 영향을        끼칠 것으로 전망       ▪ 또한, Januvia(당뇨병 치료제)가 2010년에 SFDA의 승인을 획득하였으나, Byetta(Eli Lilly)와의 경쟁이 불가피하며, NRDL        리스트에 포함되지 않아 Second-line 치료제로 남을 전망     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806354603.gif" width=587 height=137>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-10> MERCK & CO. 중국 사업 연혁     <표 70-9> MERCK & CO. 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.07</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Simcere</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트 벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>심혈관 및 대사성질환 관련 제약기업 설립</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.05</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Chongqing Zhifei</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>판매 및 마케팅</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>중국내 RotaTeq(로타바이러스 백신) 판매 및 마케팅</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.07</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>China National Pharma. Group</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공개입찰</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>HPV 백신 등 중국내 공동 판매 및 마케팅</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2008.12</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>HUYA Bioscience</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>인수</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=25 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>-</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2005.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>HD Bioscience</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>연구개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=39 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>-</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ NOVARTIS AG    - Headquater 소재 : 베이징    - 중국내 고용 인력 : 5,000여 명    - 제품 포트폴리오      ▪ 다양한 질병군의 31개 제품 포트폴리오를 구축하고 있으며, 23개 제품이 NRDL 리스트에 포함       ▪ Telbivudine(HBV 치료제)가 2007년 중국내 SFDA의 승인을 획득하였으나, 부작용으로 인하여 19세 소년이 사망하는 사고        발생       ▪ 이후 SFDA는 2개의 HBV 치료제(lamivudine, telbivudine)에 대하여 부작용을 경고하였으며, 해당 사건으로 인해        사회적으로 큰 반향을 불러일으킴     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806587916.gif" width=585 height=115>     ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-11> NOVARTIS AG 중국 사업 연혁     <표 70-10> NOVARTIS AG 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=40 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.03</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Zhejiang Tianyuan Pharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>M&A</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>$125m</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=66 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>중국 백신 생산 기업 Zhejiang Tianyuan Pharma 인수합병</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.02</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Zhejiang Huahai Pharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공급 협약</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Novartis의 글로벌 제품 공급 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2007.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>BMP Sunstone</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>인수 및 분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=73 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>중국내 Enablex(전립선질병 치료제) 등록, 판매 및 분배 협력</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ PFIZER INC.    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 9,000여 명    - 제품 포트폴리오      ▪ 가장 많은 51개의 제품 포트폴리오를 구성하고 있으며, 2000년 주력 제품인 Viagra(발기부전 치료제)가 중국내 출시       ▪ 중국제약기업의 청원으로 Viagra 특허 소송에서 2004년 특허권을 상실하였으나, 2006년 재판결을 거쳐 2014년까지 특허권에        대한 보호를 획득       ▪ Lipitor(심혈관 치료제)는 1999년 중국내 SFDA의 승인을 획득하였으나, 같은해 Beijing Jialin Pharma.의 A LE(심혈과 치료        제)가 승인되며 특허소송을 진행       ▪ 소송에서 패소하며 Lipitor의 특허권을 상실하였으나, 효능에대한 중국내 확고한 입지구축으로 손실이 크지 않음     <IMG title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364806990978.gif" width=590 height=117>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-12> PFIZER INC. 중국 사업 연혁     <표 70-11> PFIZER INC. 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.09</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Jointown Pharma.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>중국 본토 및 전역에 대한 제품 공급</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.09</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Jilin Guoyuan.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>중국내 동물 백신개발, 생산, 판매 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.06</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Zhejiang Hisun P.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>종양, 감염성 질환 제너릭 생산 판매 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.04</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Shanghi Pharma.</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>MOU</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Prevenar(폐렴구균백신) 판매 및 사용화</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.04</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Daiichi Sankyo</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공동판매</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Benicar(고혈압 치료제) 공동 판매</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.04</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Cumencor, MicuRx</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>상용화, R&D</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>결핵 Multi-Drug 연구개발 협약</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2009.09</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>BMP Sunstone</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>상용화, 분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Depo-Provera(피임제) 판매 및 공급</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2008.06</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>NovaMed</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>6개 종양치료제 판매 및 공급</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=631 colSpan=5> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>이외 4건의 연구, 분배 협력 진행</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ F.HOFFMANN-LA ROCHE    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 3,000여 명    - 제품 포트폴리오      ▪ 승인되지 않은 Avastin(대장암 치료제)이 밀수되어 노화 시력감퇴 치료제로 오용되는 사건이 발생하며 Roche의 판매에        악영향을 미침      ▪ 중국내 보건지출이 늘고있는 상황이기는 하나, 높은 약가로 인하여 중국내 종양 치료제 판매 부진     <IMG style="WIDTH: 583px; HEIGHT: 123px" title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364807060541.gif" width=614 height=128>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-13> ROCHE 중국 사업 연혁     <표 70-12> ROCHE 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=25 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Beijing Genomics Institute</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>연구개발 협력</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>지역 기반 질병 및 생물의약 연구개발 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.06</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Nycomed</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱 및 마케팅</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>아시아지역 Bonviva(골다공증 치료제) 라이센싱및 마케팅 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.11</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>CapitalBio</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Mou</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=55 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>분자진단 적용 기술 개발 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2005.12</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Shanghi Pharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱 및 마케팅</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=69 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Tamiflu(항인플루엔자) 생산 및 판매 협력</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)      ❍ SANOFI    - Headquater 소재 : 상하이    - 중국내 고용 인력 : 6,000여 명    - 제품 포트폴리오      ▪ Plavix(혈액응고 치료제)가 2001년 판매가 시작되었으며, 미국 특허가 2012년 만료됨에 따라 10개 이상의 중국 제약기업이        제너릭 생산에 들어갈 전망      ※ (Plavix) 2011년 11억 달러의 매출을 기록, 2015년 31.5억 달러의 매출을 기록할 것으로 예측       ▪ Lantus(당뇨병 치료제)가 2004년 SFDA의 승인을 획득하였으며, 2009년 NRDL 리스트에 등록되었으나 Novo Nordisk의        Levenir와의 경쟁이 불가피     <IMG style="WIDTH: 576px; HEIGHT: 164px" title="" border=0 src="https://img1.daumcdn.net/relay/cafe/original/?fname=http%3A%2F%2Fwww.bioin.or.kr%2Fupload%2F1364807114056.gif" width=589 height=163>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013) <그림 70-14> SANOFI 중국 사업 연혁     <표 70-13> SANOFI 중국내 주요 체결 협력   <TABLE style="BORDER-BOTTOM: medium none; TEXT-ALIGN: center; BORDER-LEFT: medium none; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; BORDER-COLLAPSE: collapse; FONT: 13px/9px 바탕; WHITE-SPACE: normal; LETTER-SPACING: normal; COLOR: rgb(0,0,0); BORDER-TOP: medium none; BORDER-RIGHT: medium none; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; -webkit-text-size-adjust: auto" border=1 cellSpacing=0 cellPadding=0> <TBODY> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>일자</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=119> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>파트너</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 방식</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>협약 규모</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 1.1pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" bgColor=#b3c5f3 height=17 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>주요 내용</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2012.10</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Sinopharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>MoU</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>중국환자 대상 희귀질병 공동 연구 협력</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.03</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>NT Pharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>23-valent(폐렴구균백신) 판매 및 분배</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2011.01</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>BMP Sunstone</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>인수</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>$520m</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>-</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=41 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.12</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=41 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 11px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Shanghi Institutes for Biological Science</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=41 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=41 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>$60m + 로열티</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=41 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Shanghi Institutes의 혈관생성 억제제 특허 라이센싱</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=29 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.10</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=29 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 11px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Beijing Minhai Biotech</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=29 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=29 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=29 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Beijing Minhai Biotech 광견병 백신 라이센싱</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.04</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>MMRGlobal</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>라이센싱</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=17 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>MMR 단일클론항체 라이센싱</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2010.01</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>Hangzhou Minsheng Pharma</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>조인트벤처</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 0.4pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비타민 및 미네랄 보조제 개발</TD></TR> <TR> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 1.1pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=70> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>2008.07</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=119> <P style="TEXT-ALIGN: left; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>NovaMed</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>공동판매 및 분배</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 0.4pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=74> <P style="TEXT-ALIGN: center; LINE-HEIGHT: 14px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>비공개</TD> <TD style="BORDER-BOTTOM: rgb(0,0,0) 1.1pt solid; BORDER-LEFT: rgb(0,0,0) 0.4pt solid; PADDING-BOTTOM: 1.4pt; PADDING-LEFT: 5.1pt; PADDING-RIGHT: 5.1pt; BORDER-TOP: rgb(0,0,0) 0.4pt solid; BORDER-RIGHT: rgb(0,0,0) 1.1pt solid; PADDING-TOP: 1.4pt" height=32 vAlign=center width=293> <P style="TEXT-ALIGN: justify; LINE-HEIGHT: 20px; FONT-STYLE: normal; MARGIN-TOP: 0pt; TEXT-INDENT: 0pt; FONT-FAMILY: 바탕; MARGIN-BOTTOM: 0pt; COLOR: rgb(0,0,0); FONT-SIZE: 10pt; FONT-WEIGHT: normal" class=HStyle0>항간질의약품 판매 및 분배</TD></TR></TBODY></TABLE>   ※ 출처 : Datamonitor, Big Multinational Pharma in China : Fight for Growth Drivers(2013)     <a href='javascript:fileFilterViewer("http://cfile248.uf.daum.net/attach/166DC647515FB5BE1F584F", "/cfile248/16/6DC647515FB5BE1F584F", "(13.04.01)중국내 글로벌 제약 기업[생명공학정책연구센터].pdf", "grpid%3D1QVvE%26fldid%3DGM0Y%26dataid%3D34%26fileid%3D1%26regdt%3D20130406144229&url=http%3A%2F%2Fcfile248.uf.daum.net%2Fattach%2F166DC647515FB5BE1F584F")'><img src="https://t1.daumcdn.net/daumtop_deco/icon/icon.hanmail.net/editor/p_pdf_s.gif?rv=1.0.1" border="0" alt="첨부파일" class="vam"/> (13.04.01)중국내 글로벌 제약 기업[생명공학정책연구센터].pdf</a>